Americans with a chronic disease could soon have better access to affordable treatment if a bipartisan bill just passed by the U.S. House makes it through ...

Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version ...

Aerosol Delivery Devices Market Research Report In 2019, the aerosol delivery devices market is projected to reach $46.73 billion by 2027, ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Inhalers are handheld devices that deliver medication through your mouth and lungs. They reduce inflammation in your airways and ease breathing, making them important treatments for asthma and COPD.

Am J Health Syst Pharm. 2011;68(13):1221-1232. To receive Medicare Part D prescription drug coverage, patients must also subscribe to Medicare Parts A and B. Part B medication coverage is ...

Background: The proliferation of inhaler devices has resulted in a confusing number of choices for clinicians who are selecting a delivery device for aerosol therapy. There are advantages and ...

The rising prevalence of respiratory diseases and technological advancements drive significant market growth.Pune, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aerosol Drug Delivery Devices Market Size & Growth ...

Biomedical engineering students at Johns Hopkins developed a device that could help clinicians detect and treat smell ...

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...